
Evidence-Based Oncology Examines Impact of Quality Measures in Cancer Care
What is the best way to measure quality care in cancer? As explored in the current issue of Evidence-Based Oncology, it depends on who you ask, and which tools are used to evaluate care.
PLAINSBORO, N.J.—Quality metrics are proliferating in cancer care, and are derived from many of the same sources, yet in many ways they remain in the eye of the beholder, according to experts who offered insights and commentary in the current issue of Evidence-Based Oncology (EBO), a publication of The American Journal of Managed Care. For the full issue,
For the American Society of Clinical Oncology (ASCO), a key step to measuring quality in cancer care has been assembling data through the creation
The issue also features coverage of a panel discussion with three experts who have successfully implemented the American College of Surgeons’
Two articles in the issue explore the need for better patient reported outcomes, or PROs. Authors from the
Authors from the group PatientsLikeMe and Actelion Pharmaceuticals collaborated on an article about a project funded by
EBO editor-in-chief Joseph Alvarnas, MD, reminded readers that while metrics are important, they do not solve all the issues with quality. “As cancer care stakeholders move through processes of creating, deploying, and reporting quality metrics, it is important to remember that these measures alone are not sufficient to bring better care to patients,” he writes. “Cancer care quality measures are not the equivalent of baseball sabermetrics; there is no easy, metric-based fast-track toward creating a less costly, more effective cancer care delivery system.”
About the Journals and AJMC.com
The American Journal of Managed Care is the leading peer-reviewed journal dedicated to issues in managed care.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.